Welcome to our dedicated page for Jupiter Wellness SEC filings (Ticker: SHOTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Safety Shot, Inc. (Nasdaq: SHOT), which later announces a name change to Bonk, Inc. and a new ticker symbol BNKK, document the company’s corporate evolution, capital structure, and integration with the BONK digital asset ecosystem. Investors reviewing these filings can see how the company uses registered direct offerings, private placements, and preferred stock to finance its strategy and formalize revenue sharing arrangements tied to letsBONK.fun.
Recent Forms 8-K describe material definitive agreements, including Securities Purchase Agreements for common stock and warrants, PIPE transactions where BONK tokens are used as consideration, and the issuance of Series B and Series C preferred stock. The filings outline conversion prices, voting rights, dividend provisions, and the treatment of preferred shares in liquidation, providing detail on how these instruments relate to common stock. They also disclose a Revenue Sharing Agreement granting Safety Shot 10% of all gross revenue of letsBONK.fun in perpetuity, in exchange for Series C Preferred Stock.
Other 8-Ks report governance and executive changes, such as the appointment of a new Chief Financial Officer, the resignation of prior officers, and the addition of BONK core contributor Mitchell Rudy to the Board of Directors. Filings also include a Nasdaq notice regarding non-compliance with the minimum bid price requirement and an extension period to regain compliance.
Through Stock Titan’s interface, users can access these SEC filings as they are made available on EDGAR and benefit from AI-powered summaries that explain key points in plain language. This includes highlights from annual reports on Form 10-K and quarterly reports on Form 10-Q when filed, as well as current reports on Form 8-K and any proxy materials. Investors can also review disclosures related to preferred stock designations and capital raises to understand dilution, voting power, and the company’s approach to funding its BONK-focused strategy.